XenoTech specializes in drug metabolism and drug-drug interaction studies, providing high-quality contracted ADME studies and test systems to support clinical trials.

XenoTech

Celerion provides clinical research solutions, focusing on early phase services, bioanalytical sciences, drug development and regulatory affairs, and data management. The company utilizes agile research strategies to support the development of drugs and therapies.

Celerion

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).

Metric
Company Name	XenoTech	Celerion	Thermo Fisher Scientific, Inc.
Symbol			TMO
MSH ID	COM:XENOTECH	COM:CELERION	COM:THERMOFISHER
Market	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Pharmaceutical Services	Pharmaceuticals	Medical - Diagnostics & Research
Country	US	US	US
Stage
Employee Count			122K
Website	xenotech.com	celerion.com	thermofisher.com
LinkedIn
Founders

Metric
Market Cap			196.32B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue			42.86B
Revenue (LTM)
Revenue (NTM)
Gross Profit			17.56B
EBITDA			6.86B
Operating Income			6.86B
Net Income			6.00B
EPS			15.53
Diluted EPS			15.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score			95.08
28-Day Growth Score			13.40
90-Day Growth Score			10.50
365-Day Growth Score			71.57

Metric
Gross Profit Margin			0.42
Operating Profit Margin			0.17
EBITDA Margin			0.16
Net Profit Margin			0.15
Return on Equity			0.13
Return on Assets			0.06
Return on Capital Employed			0.09

COM:XENOTECH

XenoTech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			35.85
P/B Ratio			4.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			5.61
EV Multiple			20.87

Metric
Days Sales Outstanding			70.36
Days Payables Outstanding			35.73
Days Inventory Outstanding			76.60
Operating Cycle			157.60
Cash Conversion Cycle			145.06
Asset Turnover			0.44

Metric
Operating Cash Flow			8.41B
Free Cash Flow			6.93B
Cash Flow to Debt			0.26
Operating Cash Flow/Sales			0.22
Free Cash Flow Yield			0.03

Metric
Cash & Equivalents			8.08B
Accounts Receivable			-43M
Inventory			5.09B
Goodwill			44.02B
Debt to Capitalization			0.44
Debt to Assets			0.36
Current Ratio			1.63
Quick Ratio			1.37

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			-0.00
R&D to Revenue			0.03
SG&A to Revenue